Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V

Microbial Biotechnology

Volumn 3, Issue 4, 2010, Pages 473-486

  Field, Des ^a   Quigley, Lisa ^a   O'Connor, Paula M ^b   Rea, Mary C ^b   Daly, Karen ^a   Cotter, Paul D ^b,c   Hill, Colin ^a,c   Ross, R Paul ^b,c  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; FOOD PRESERVATIVE; NISIN A; NISIN T; NISIN V; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL DISEASE; ARTICLE; BACILLUS CEREUS; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIOENGINEERING; BOVINE MASTITIS; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DRUG POTENCY; FOOD POISONING; HETEROGENOUS VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS; LISTERIA MONOCYTOGENES; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; PURIFICATION; STAPHYLOCOCCUS; STREPTOCOCCUS; VANCOMYCIN RESISTANT ENTEROCOCCUS;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; BACTERIOCINS; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; NISIN;

BACILLUS CEREUS; BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE; LISTERIA MONOCYTOGENES; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; POSIBACTERIA; STAPHYLOCOCCUS;

EID: 77954168712     PISSN: 17517907     EISSN: 17517915     Source Type: Journal    
DOI: 10.1111/j.1751-7915.2010.00184.x     Document Type: Article

References (89)

1. Akerey, B., Le-Lay, C., Fliss, I., Subirade, M., and Rouabhia, M. (2009) In vitro efficacy of nisin Z against Candida albicans adhesion and transition following contact with normal human gingival cells. J Appl Microbiol 107: 1298-1307.
2. Aranha, C., Gupta, S., and Reddy, K.V. (2004) Contraceptive efficacy of antimicrobial peptide Nisin: in vitro and in vivo studies. Contraception 69: 333-338. (Pubitemid 38366466)
3. Arvand, M., Hauri, A.M., Zaiss, N.H., Witte, W., and Bettge-Weller, G. (2009) Clostridium difficile ribotypes 001, 017, and 027 are associated with lethal C. difficile infection in Hesse, Germany. Euro Surveill 14: 19403.
4. Badaoui Najjar, M., Kashtanov, D., and Chikindas, M. (2009) Natural antimicrobials e-poly-l-lysine and Nisin A for control of oral microflora. Probiotics Antimicrob Proteins 1: 143-147.
5. Bavin, E.M., Beach, A.S., Falconer, R., and Friedmann, R. (1952) Nisin in experimental tuberculosis. Lancet 1: 127-129.
6. Begley, M., Hill, C., and Ross, R.P. (2006) Tolerance of listeria monocytogenes to cell envelope-acting antimicrobial agents is dependent on SigB. Appl Environ Microbiol 72:2231-2234.
7. Beuchat, L.R., Clavero, M.R., and Jaquette, C.B. (1997) Effects of nisin and temperature on survival, growth, and enterotoxin production characteristics of psychrotrophic Bacillus cereus in beef gravy. Appl Environ Microbiol 63:1953-1958.
8. Bierbaum, G., and Sahl, H.G. (2009) Lantibiotics: mode of action, biosynthesis and bioengineering. Curr Pharm Biotechnol 10: 2-18.
9. Boakes, S., and Wadman, S. (2009) The therapeutic potential of lantibiotics. Innov Pharm Technol 22-25.
10. Bonelli, R.R., Schneider, T., Sahl, H.G., and Wiedemann, I. (2006) Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies. Antimicrob Agents Chemother 50: 1449-1457.
11. Brazier, J.S., Fawley, W., Freeman, J., and Wilcox, M.H. (2001) Reduced susceptibility of Clostridium difficile to metronidazole. J Antimicrob Chemother 48: 741-742. (Pubitemid 33100327)
12. Breukink, E., and de Kruijff, B. (1999) The lantibiotic nisin, a special case or not? Biochim Biophys Acta 1462: 223-234.
13. Breukink, E., and de Kruijff, B. (2006) Lipid II as a target for antibiotics. Nat Rev Drug Discov 5: 321-332.
14. Breukink, E., Wiedemann, I., van Kraaij, C., Kuipers, O.P., Sahl, H., and de Kruijff, B. (1999) Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 286: 2361-2364. (Pubitemid 30016902)
15. Brumfitt, W., Salton, M.R., and Hamilton-Miller, J.M. (2002) Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. J Antimicrob Chemother 50: 731-734.
16. Bugg, T.D., Wright, G.D., Dutka-Malen, S., Arthur, M., Courvalin, P., and Walsh, C.T. (1991) Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Biochemistry 30: 10408-10415.
17. Cao, L.T., Wu, J.Q., Xie, F., Hu, S.H., and Mo, Y. (2007) Efficacy of nisin in treatment of clinical mastitis in lactating dairy cows. J Dairy Sci 90: 3980-3985. (Pubitemid 350063987)
18. Chatterjee, C., Paul, M., Xie, L., and van der Donk, W.A. (2005) Biosynthesis and mode of action of lantibiotics. Chem Rev 105: 633-684.
19. Chen, H., and Hoover, D.G. (2003) Bacteriocins and their food applications. Compr Rev Food Sci Food Saf 2:82-100.
20. Chi-Zhang, Y., Yam, K.L., and Chikindas, M.L. (2004) Effective control of Listeria monocytogenes by combination of nisin formulated and slowly released into a broth system. Int J Food Microbiol 90: 15-22. (Pubitemid 37522204)
21. Chollet, E., Sebti, I., Martial-Gros, A., and Degraeve, P. (2008) Nisin preliminary study as a potential preservative for sliced ripened cheese: NaCl, fat and enzymes influence on nisin concentration and its antimicrobial activity. Food Control 19: 982-989. (Pubitemid 351662403)
22. Cotter, P.D., Emerson, N., Gahan, C.G.M., and Hill, C. (1999) Identification and disruption of lisRK, a genetic locus encoding a two-component signal transduction system involved in stress tolerance and virulence in Listeria monocytogenes. J Bacteriol 181: 6840-6843. (Pubitemid 29518003)
23. Cotter, P.D., Guinane, C.M., and Hill, C. (2002) The LisRK signal transduction system determines the sensitivity of Listeria monocytogenes to nisin and cephalosporins. Antimicrob Agents Chemother 46: 2784-2790.
24. Cotter, P.D., Hill, C., and Ross, R.P. (2003) A food-grade approach for functional analysis and modification of native plasmids in Lactococcus lactis. Appl Environ Microbiol 69:702-706. (Pubitemid 36077545)
25. Cotter, P.D., Hill, C., and Ross, R.P. (2005a) Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 3:777-788.
26. Cotter, P.D., Connor, P.M.O., Draper, L.A., Lawton, E.M., Deegan, L.H., Hill, C., and Ross, R.P. (2005b) Posttranslational conversion of L-serines to d-alanines is vital for optimal production and activity of the lantibiotic lacticin 3147. Proc Natl Acad Sci USA 102: 18584-18589.
27. Cotter, P.D., Deegan, L.H., Lawton, E.M., Draper, L.A., O'Connor, P.M., Hill, C., and Ross, R.P. (2006a) Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design. Mol Microbiol 62: 735-747.
28. Cotter, P.D., Draper, L.A., Lawton, E.M., McAuliffe, O., Hill, C., and Ross, R.P. (2006b) Overproduction of wild-type and bioengineered derivatives of the lantibiotic lacticin 3147. Appl Environ Microbiol 72: 4492-4496.
29. Cui, L., Iwamoto, A., Lian, J.-Q., Neoh, H.-m., Maruyama, T., Horikawa, Y., and Hiramatsu, K. (2006) Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 50: 428-438.
30. Davies, E.A., Milne, C.F., Bevis, H.E., Potter, R.W., Harris, J.M., Williams, G.C., et al. (1999) Effective use of nisin to control lactic acid bacterial spoilage in vacuum-packed bologna-type sausage. J Food Prot 62: 1004-1010.
31. De Kwaadsteniet, M., Doeschate, K.T., and Dicks, L.M. (2009) Nisin F in the treatment of respiratory tract infections caused by Staphylococcus aureus. Lett Appl Microbiol 48: 65-70.
32. Deegan, L.H., Cotter, P.D., Hill, C., and Ross, P. (2006) Bacteriocins: biological tools for bio-preservation and shelf-life extension. Int Dairy J 16: 1058-1071.
33. Delves-Broughton, J. (1990) Nisin and its uses as a food preservative. Food Technol 44: 100-117.
34. Fernandez, L., Delgado, S., Herrero, H., Maldonado, A., and Rodriguez, J.M. (2008) The bacteriocin nisin, an effective agent for the treatment of staphylococcal mastitis during lactation. J Hum Lact 24: 311-316.
35. Field, D., Collins, B., Cotter, P.D., Hill, C., and Ross, R.P. (2007) A system for the random mutagenesis of the two-peptide lantibiotic lacticin 3147: analysis of mutants producing reduced antibacterial activities. J Mol Microbiol Biotechnol 13: 226-234.
36. Field, D., Connor, P.M., Cotter, P.D., Hill, C., and Ross, R.P. (2008) The generation of nisin variants with enhanced activity against specific gram-positive pathogens. Mol Microbiol 69: 218-230.
37. Fitzgerald, J.R., Meaney, W.J., Hartigan, P.J., Smyth, C.J., and Kapur, V. (1997) Fine-structure molecular epidemiological analysis of Staphylococcus aureus recovered from cows. Epidemiol Infect 119: 261-269. (Pubitemid 27474808)
38. Goldstein, B.P., Wei, J., Greenberg, K., and Novick, R. (1998) Activity of nisin against Streptococcus pneumoniae, in vitro, and in a mouse infection model. J Antimicrob Chemother 42: 277-278. (Pubitemid 28393607)
39. Grundmann, H., Aires-de-Sousa, M., Boyce, J., and Tiemersma, E. (2006) Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368: 874-885. (Pubitemid 44308640)
40. Guinane, C.M., Cotter, P.D., Hill, C., and Ross, R.P. (2005) Microbial solutions to microbial problems; lactococcal bacteriocins for the control of undesirable biota in food. J Appl Microbiol 98: 1316-1325. (Pubitemid 40813518)
41. Gupta, S.M., Aranha, C.C., Bellare, J.R., and Reddy, K.V.R. (2009) Interaction of contraceptive antimicrobial peptide nisin with target cell membranes: implications for use as vaginal microbicide. Contraception 80: 299-307.
42. Hamada, S., and Slade, H.D. (1980) Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol Mol Biol Rev 44: 331-384. (Pubitemid 11128312)
43. Hancock, R.E.W., and Sahl, H.-G. (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24: 1551-1557.
44. Holo, H., and Nes, I.F. (1995) Transformation of Lactococcus by electroporation. Methods Mol Biol 47: 195-199.
45. Hookman, P., and Barkin, J.S. (2009) Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol 15: 1554-1580.
46. Howden, B.P., Johnson, P.D.R., Ward, P.B., Stinear, T.P., and Davies, J.K. (2006) Isolates with Low-Level Vancomycin Resistance Associated with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia. Antimicrob Agents Chemother 50: 3039-3047.
47. Howell, T.H., Fiorellini, J.P., Blackburn, P., Projan, S.J., de la Harpe, J., and Williams, R.C. (1993) The effect of a mouthrinse based on nisin, a bacteriocin, on developing plaque and gingivitis in beagle dogs. J Clin Periodontol 20:335-339. (Pubitemid 23274601)
48. Jung, D.-S., Bodyfelt, F.W., and Daeschel, M.A. (1992) Influence of fat and emulsifiers on the efficacy of nisin in inhibiting Listeria monocytogenes in fluid milk. J Dairy Sci 75:387-393.
49. Kerr, K.G., Copley, R.M., and Wilcoy, M.H. (1997) Activity of nisin against Clostridium difficile. Lancet 349: 1026-1027.
50. Kuipers, O.P., Beerthuyzen, M.M., Siezen, R.J., and De Vos, W.M. (1993) Characterization of the nisin gene cluster nis-ABTCIPR of Lactococcus lactis. Requirement of expression of the nisA and nisI genes for development of immunity. Eur J Biochem 216: 281-291.
51. Kuipers, O.P., Bierbaum, G., Ottenwalder, B., Dodd, H.M., Horn, N., Metzger, J., et al. (1996) Protein engineering of lantibiotics. Antonie Van Leeuwenhoek 69: 161-169.
52. Kuipers, O.P., De Ruyter, P.G., Kleerebezem, M., and De Vos, W.M. (1998) Quorum sensing-controlled gene expression in lactic acid bacteria. J Biotechnol 64: 15-21. (Pubitemid 29027781)
53. Law, J., Buist, G., Haandrikman, A., Kok, J., Venema, G., and Leenhouts, K. (1995) A system to generate chromosomal mutations in Lactococcus lactis which allows fast analysis of targeted genes. Appl Environ Microbiol 177: 7011-7018.
54. Lawton, E.M., Ross, R.P., Hill, C., and Cotter, P.D. (2007) Two-peptide lantibiotics: a medical perspective. Mini Rev Med Chem 7: 1236-1247.
55. Leenhouts, K., Buist, G., Bolhuis, A., ten Berge, A., Kiel, J., Mierau, I., et al. (1996) A general system for generating unlabelled gene replacements in bacterial chromosomes. Mol Gen Genet 253: 217-224.
56. Linnan, M.J., Mascola, L., Lou, X.D., Goulet, V., May, S., Salminen, C., et al. (1988) Epidemic listeriosis associated with Mexican-style cheese. N Engl J Med 319: 823-828.
57. Loesche, W.J. (1986) Role of Streptococcus mutans in human dental decay. Microbiol Mol Biol Rev 50: 353-380.
58. Lotte, P.S.A., Annette, F., and Per Einar, G. (2008) From soil to gut: Bacillus cereus and its food poisoning toxins. FEMS Microbiol Rev 32: 579-606.
59. McAuliffe, O., Ross, R.P., and Hill, C. (2001) Lantibiotics: structure, biosynthesis and mode of action. FEMS Microbiol Rev 25: 285-308. (Pubitemid 32429585)
60. Maguin, E., Duwat, P., Hege, T., Ehrlich, D., and Gruss, A. (1992) New thermosensitive plasmid for gram-positive bacteria. J Bacteriol 174: 5633-5638.
61. Mascola, L., Lieb, L., Fannin, S.L., Chiu, J., and Linnan, M.J. (1988) Listeriosis: an uncommon opportunistic infection in patients with acquired immunodeficiency syndrome: a report of five cases and a review of the literature. Am J Med 84: 162-164.
62. Murray, M., and Richard, J.A. (1997) Comparative study of the antilisterial activity of nisin A and pediocin AcH in fresh ground pork stored aerobically at 5° C. J Food Prot 60:1534-1540.
63. Pelaez, T., Alcala, L., Alonso, R., Rodriguez-Creixems, M., Garcia-Lechuz, J.M., and Bouza, E. (2002) Reassessment of Clostridium difficile susceptibility to Metronidazole and Vancomycin. Antimicrob Agents Chemother 46: 1647-1650.
64. Piper, C., Cotter, P.D., Ross, R.P., and Hill, C. (2009a) Discovery of medically significant lantibiotics. Curr Drug Discov Technol 6: 1-18.
65. Piper, C., Draper, L.A., Cotter, P.D., Ross, R.P., and Hill, C. (2009b) A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species. J Antimicrob Chemother 63: 546-551.
66. Rabello, R.F., Souza, C.R.V.M., Duarte, R.S., Lopes, R.M.M., Teixeira, L.M., and Castro, A.C.D. (2005) Characterization of Staphylococcus aureus isolates recovered from bovine mastitis in Rio de Janeiro, Brazil. J Dairy Sci 88: 3211-3219.
67. Reddy, K.V., Aranha, C., Gupta, S.M., and Yedery, R.D. (2004) Evaluation of antimicrobial peptide nisin as a safe vaginal contraceptive agent in rabbits: in vitro and in vivo studies. Reproduction 128: 117-126.
68. Riedel, C.U., Monk, I.R., Casey, P.G., Morrissey, D., O'Sullivan, G.C., Tangney, M., et al. (2007) Improved luciferase tagging system for Listeria monocytogenes allows real-time monitoring in vivo and in vitro. Appl Environ Microbiol 73: 3091-3094.
69. Rink, R., Wierenga, J., Kuipers, A., Kluskens, L.D., Driessen, A.J., Kuipers, O.P., and Moll, G.N. (2007) Dissection and modulation of the four distinct activities of nisin by mutagenesis of rings A and B and by C-terminal truncation. Appl Environ Microbiol 73: 5809-5816.
70. Schlech, W.F., III (2000) Foodborne listeriosis. Clin Infect Dis 31: 770-775.
71. Sears, P.M., Smith, B.S., Stewart, W.K., Gonzalez, R.N., Rubino, S.D., Gusik, S.A., et al. (1992) Evaluation of a nisin-based germicidal formulation on teat skin of live cows. J Dairy Sci 75: 3185-3190.
72. Severina, E., Severin, A., and Tomasz, A. (1998) Antibacterial efficacy of nisin against multidrug-resistant Grampositive pathogens. J Antimicrob Chemother 41: 341-347.
73. Sobrino-Lopez, A., and Martin-Belloso, O. (2008) Use of nisin and other bacteriocins for preservation of dairy products. Int Dairy J 18: 329-343.
74. von Staszewski, M., and Jagus, R.J. (2008) Natural antimicrobials: effect of microgard(TM) and nisin against Listeria innocua in liquid cheese whey. Int Dairy J 18: 255-259.
75. Turner, S.R., Love, R.M., and Lyons, K.M. (2004) An in-vitro investigation of the antibacterial effect of nisin in root canals and canal wall radicular dentine. Int Endod J 37:664-671.
76. Twomey, D., Ross, R.P., Ryan, M., Meaney, B., and Hill, C. (2002) Lantibiotics produced by lactic acid bacteria: structure, function and applications. Antonie Van Leeuwenhoek 82: 165-185.
77. Vignolo, G., Palacios, J., Farias, M.E., Sesma, F., Schillinger, U., Holzapfel, W., and Oliver, G. (2000) Combined effect of bacteriocins on the survival of various Listeria species in broth and meat system. Curr Microbiol 41: 410-416.
78. Viguier, C., Arora, S., Gilmartin, N., Welbeck, K., and O'Kennedy, R. (2009) Mastitis detection: current trends and future perspectives. Trends Biotechnol 27: 486-493.
79. Wan, A.K.L., Seow, W.K., Purdie, D.M., Bird, P.S., Walsh, L.J., and Tudehope, D.I. (2003) A longitudinal study of Streptococcus mutans colonization in infants after tooth eruption. J Dent Res 82: 504-508.
80. Warriner, K., and Namvar, A. (2009) What is the hysteria with Listeria? Trends Food Sci Technol 20: 245-254.
81. Wiedemann, I., Breukink, E., van Kraaij, C., Kuipers, O.P., Bierbaum, G., de Kruijff, B., and Sahl, H.G. (2001) Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J Biol Chem 276: 1772-1779.
82. Wiedemann, I., Bottiger, T., Bonelli, R.R., Wiese, A., Hagge, S.O., Gutsmann, T., et al. (2006) The mode of action of the lantibiotic lacticin 3147 - a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol Microbiol 61: 285-296.
83. Wolf, C.E., and Gibbons, W.R. (1996) Improved method for quantification of the bacteriocin nisin. J Appl Bacteriol 80:453-457.
84. World Health Organization (1969) Specifications for identity and purity of some antibiotics. World Health Organization/Food Add 69: 53-67.
85. Wu, J., Hu, S., and Cao, L. (2007) Therapeutic effect of nisin Z on subclinical mastitis in lactating cows. Antimicrob Agents Chemother 51: 3131-3135. (Pubitemid 350067519)
86. Yuan, J., Zhang, Z.Z., Chen, X.Z., Yang, W., and Huan, L.D. (2004) Site-directed mutagenesis of the hinge region of nisinZ and properties of nisinZ mutants. Appl Microbiol Biotechnol 64: 806-815.
87. Zadoks, R., van Leeuwen, W., Barkema, H., Sampimon, O., Verbrugh, H., Schukken, Y.H., and van Belkum, A. (2000) Application of pulsed-field gel electrophoresis and binary typing as tools in veterinary clinical microbiology and molecular epidemiologic analysis of bovine and human Staphylococcus aureus isolates. J Clin Microbiol 38: 1931-1939.
88. Zadoks, R.N., and Fitzpatrick, J.L. (2009) Changing trends in mastitis. Ir Vet J 62: 59-70.
89. Zinn, C.S., Westh, H., Rosdahl, V.T., and Group, S.S. (2004) An international multicenter study of antimicrobial resistance and typing of hospital Staphylococcus aureus isolates from 21 laboratories in 19 countries or states. Microb Drug Resist 10: 160-168. (Pubitemid 38879017)